<VariationArchive VariationID="2664741" VariationName="NM_003079.5(SMARCE1):c.587del (p.Phe196fs)" VariationType="Deletion" Accession="VCV002664741" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2023-12-17" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2832191" VariationID="2664741">
      <GeneList>
        <Gene Symbol="SMARCE1" FullName="SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1" GeneID="6605" HGNC_ID="HGNC:11109" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="40624962" stop="40647818" display_start="40624962" display_stop="40647818" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="38783971" stop="38804102" display_start="38783971" display_stop="38804102" Strand="-" />
          </Location>
          <OMIM>603111</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003079.5(SMARCE1):c.587del (p.Phe196fs)</Name>
      <CanonicalSPDI>NC_000017.11:40632321:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="40632322" stop="40632322" display_start="40632322" display_stop="40632322" variantLength="1" positionVCF="40632321" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="38788574" stop="38788574" display_start="38788574" display_stop="38788574" variantLength="1" positionVCF="38788573" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F196fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.38788576del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.38788576del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.40632324del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.40632324del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032163.1" sequenceAccession="NG_032163" sequenceVersion="1" change="g.20530del">
            <Expression>NG_032163.1:g.20530del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003079.5" sequenceAccession="NM_003079" sequenceVersion="5" change="c.587del" MANESelect="true">
            <Expression>NM_003079.5:c.587del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003070.3" sequenceAccession="NP_003070" sequenceVersion="3" change="p.Phe196fs">
            <Expression>NP_003070.3:p.Phe196fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003079.5" sequenceAccession="NM_003079" sequenceVersion="5" change="c.587delT" MANESelect="true">
            <Expression>NM_003079.5:c.587delT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003079.4" sequenceAccession="NM_003079" sequenceVersion="4" change="c.587delT">
            <Expression>NM_003079.4:c.587delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003079.5(SMARCE1):c.587del (p.Phe196fs) AND Familial meningioma" Accession="RCV003447716" Version="2">
        <ClassifiedConditionList TraitSetID="6615">
          <ClassifiedCondition DB="MedGen" ID="C3551915">Familial meningioma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-12-17" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26803492</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33020650</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">37164167</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">23556151</ID>
          <ID Source="BookShelf">NBK131811</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6615" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2843" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Meningioma, familial, susceptibility to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial meningioma</ElementValue>
                <XRef ID="MONDO:0011789" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with MN1 C-terminal truncation (MCTT) syndrome have mild-to-moderate intellectual disability, severe expressive language delay, dysmorphic facial features (midface hypoplasia, downslanting palpebral fissures, hypertelorism, exophthalmia, short upturned nose, and small low-set ears), and distinctive findings on brain imaging (including perisylvian polymicrogyria and atypical rhombencephalosynapsis). Mild-to-moderate prelingual hearing loss (usually bilateral, conductive, and/or sensorineural) is common. Generalized seizures (observed in the minority of individuals) are responsive to anti-seizure medication. There is an increased risk for craniosynostosis and, thus, increased intracranial pressure. To date, 25 individuals with MCTT syndrome have been identified.</Attribute>
                <XRef ID="NBK560443" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18385" />
                <XRef ID="18385" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32790267</ID>
                <ID Source="BookShelf">NBK560443</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng99</URL>
                <CitationText>UK NICE Guideline NG99, Brain tumours (primary) and brain metastases in over 16s, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Central Nervous System Cancers, 2023</CitationText>
              </Citation>
              <XRef ID="263662" DB="Orphanet" />
              <XRef ID="C3551915" DB="MedGen" />
              <XRef ID="MONDO:0011789" DB="MONDO" />
              <XRef Type="MIM" ID="607174" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7813451" SubmissionDate="2023-12-11" DateLastUpdated="2023-12-17" DateCreated="2023-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/genomics_unit/vc36302" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004175384" DateUpdated="2023-12-17" DateCreated="2023-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SMARCE1 c.587del variant is classified as PATHOGENIC (PVS1, PM2, PP4) This SMARCE1 c.587del variant is located in exon 8/11 and is predicted to cause a shift in the reading frame at codon 196, leading to the introduction of a premature stop codon (PVS1). This variant is absent from population databases (PM2). The clinical features of this case are highly specific for the genes tested as part of this panel and this patient has a well-defined syndrome with little overlap with other clinical presentations (PP4). This variant has not been reported in dbSNP, ClinVar or HGMD.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_18277</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003079.5:c.587delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607174" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_40</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9874372" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_003079_4_SMARCE1_c_587delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005087247" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23556151</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26803492</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33020650</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">37164167</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with susceptibility to familial meningioma (MIM#607174) and Coffin-Siris syndrome 5 (MIM#616938), respectively (PMIDs: 23556151, 26803492, 37164167). Dominant negative has also been reported for the latter (PMID: 23556151). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other premature termination variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Many germline NMD-predicted variants in this gene have been reported in families with clear cell meningioma (PMID: 37164167). These variants have also been reported as likely pathogenic/pathogenic in the context of familial meningioma or hereditary cancer-predisposing syndrome (ClinVar). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. It has been reported in a child with an unspecified cancer in the central nervous system (PMID: 33020650). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_18277</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003079.4:c.587delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607174" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874372" TraitType="Disease" MappingType="XRef" MappingValue="607174" MappingRef="OMIM">
        <MedGen CUI="C3551915" Name="Familial meningioma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7813451" TraitType="Disease" MappingType="XRef" MappingValue="607174" MappingRef="OMIM">
        <MedGen CUI="C3551915" Name="Familial meningioma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

